Cerus
CERS
$1.71
Share price
0.59%
Change (1 day)
-25.97%
Change (1 year)
Categories
Cerus (CERS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.14 B
According to Cerus's latest financial reports the company's total liabilities are $0.14 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Cerus - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.14 B | -3.49% |
| 2022-12-31 | $0.14 B | -1.55% |
| 2021-12-31 | $0.15 B | 29.14% |
| 2020-12-31 | $0.11 B | 8.41% |
| 2019-12-31 | $0.10 B | 37.42% |
| 2018-12-31 | $78.94 M | 33.11% |
| 2017-12-31 | $59.3 M | 29.8% |
| 2016-12-31 | $45.68 M | 2.36% |
| 2015-12-31 | $44.63 M | 10.89% |
| 2014-12-31 | $40.25 M | -0.82% |
| 2013-12-31 | $40.58 M | 36.14% |
| 2012-12-31 | $29.81 M | 10.19% |
| 2011-12-31 | $27.05 M | 10.72% |
| 2010-12-31 | $24.43 M | 87.34% |
| 2009-12-31 | $13.04 M | -0.14% |
| 2008-12-31 | $13.06 M | -28.71% |
| 2007-12-31 | $18.32 M | 23.41% |
| 2006-12-31 | $14.84 M | -36.51% |
| 2005-12-31 | $23.38 M | -70.98% |
| 2004-12-31 | $80.58 M | 22.22% |
| 2003-12-31 | $65.93 M | 292.98% |
| 2002-12-31 | $16.77 M | -21.98% |
| 2001-12-31 | $21.5 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $15.60 B | 10,714.67% | 🇺🇸 USA |
 Utah Medical Products UTMD | $7.54 M | -94.77% | 🇺🇸 USA |
 Haemonetics HAE | $1.25 B | 771.15% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $46.89 M | -67.50% | 🇺🇸 USA |